Metabolism, disease contexts & sugars
p53–ASS1–Akt Pathway
Bibliographic records for p53–ASS1–Akt Pathway. 5 records, version 2026-08-17.1, reference date 2026-08-17, 100 per page.
0 records lack a publication year. Patents and preprints are distinguished from scholarly articles using source publication types.
Additional records sharing normalized titles: 0. These are potential matches, not confirmed duplicate publications.
Search by keywords, year, study design or publication status →
Bibliographic records
1–5 of 5 records; page 1 of 1
Role of genetic factors in imatinib resistance of chronic myeloid leukemia: P53, RB1, ASS1 gene deletions, and chromosome 8 hyperdiploidy.Scholarly articleOther literature / recordsHumanActivePathology, research and practice2025
Hasanova A, Asadov C, Shirinova A, et al.
Sestrin3 confers resistance to recombinant human arginase in small cell lung cancer by activating Akt/mTOR/ASS1 axis.Scholarly articleOther literature / recordsHuman & animalActivePloS one2025
Zhang Z, Lin Z, Li W, et al.
β-Sitosterol targets ASS1 for Nrf2 ubiquitin-dependent degradation, inducing ROS-mediated apoptosis via the PTEN/PI3K/AKT signaling pathway in ovarian cancer.Scholarly articleOther literature / recordsHumanActiveFree radical biology & medicine2024
Wang H, Liu J, Zhang Z, et al.
ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.Scholarly articleOther literature / recordsHumanCorrectedNature metabolism2024
Lim LQJ, Adler L, Hajaj E, et al.
Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53.Scholarly articleOther literature / recordsHuman & animalActiveScience advances2017
Miyamoto T, Lo PHY, Saichi N, et al.
First page →